SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-039678
Filing Date
2012-07-16
Accepted
2012-07-16 17:20:24
Documents
6
Period of Report
2012-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v318691_8k.htm 8-K 39068
2 EXHIBIT 2.1 v318691_ex2-1.htm EX-2.1 488328
3 EXHIBIT 4.1 v318691_ex4-1.htm EX-4.1 30136
4 EXHIBIT 99.1 v318691_ex99-1.htm EX-99.1 16491
5 EXHIBIT 99.2 v318691_ex99-2.htm EX-99.2 15194
6 GRAPHIC logo.jpg GRAPHIC 18825
  Complete submission text file 0001144204-12-039678.txt   616599
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10827 | Film No.: 12964280
SIC: 2834 Pharmaceutical Preparations